BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 12842411)

  • 1. Management of gestational trophoblastic diseases in Japan--a review.
    Sasaki S
    Placenta; 2003 Apr; 24 Suppl A():S28-32. PubMed ID: 12842411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
    Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
    Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and radiological features of gestational trophoblastic tumors].
    Mamouni N; Boumhaoued S; Erraghay S; Boubou M; Bouchikhi C; Banani A
    Pan Afr Med J; 2017; 28():228. PubMed ID: 29629014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of hydatidiform mole and persistent trophoblastic disease: diagnostic accuracy of total human chorionic gonadotropin (hCG), free hCG {alpha}- and {beta}-subunits, and their ratios.
    van Trommel NE; Sweep FC; Schijf CP; Massuger LF; Thomas CM
    Eur J Endocrinol; 2005 Oct; 153(4):565-75. PubMed ID: 16189178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modern management of gestational trophoblastic disease.
    McDonald TW; Ruffolo EH
    Obstet Gynecol Surv; 1983 Feb; 38(2):67-83. PubMed ID: 6300738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
    Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
    Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current approaches to diagnosis and treatment of gestational trophoblastic disease.
    Smith DB; O'Reilly SM; Newlands ES
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):84-91. PubMed ID: 8381037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
    Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
    Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory correlates of molar pregnancy and trophoblastic disease.
    Morrow CP; Kletzky OA; Disaia PJ; Townsend DE; Mishell DR; Nakamura RM
    Am J Obstet Gynecol; 1977 Jun; 128(4):424-30. PubMed ID: 194480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of gestational trophoblastic disease in developing countries.
    Sivanesaratnam V
    Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):925-42. PubMed ID: 14614890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trophoblastic disease.
    Ngan HY; Kohorn EI; Cole LA; Kurman RJ; Kim SJ; Lurain JR; Seckl MJ; Sasaki S; Soper JT
    Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 2():S130-6. PubMed ID: 22999504
    [No Abstract]   [Full Text] [Related]  

  • 12. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
    Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
    Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
    Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
    Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of hyperglycosylated hCG in serum taken before hydatidiform mole evacuation to predict persistent trophoblastic disease.
    Duc HN; van Trommel NE; Sweep FC; Massuger LF; Thomas CM
    Int J Biol Markers; 2006; 21(1):45-9. PubMed ID: 16711513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of serum chorionic gonadotropin and placental lactogen in trophoblastic disease.
    Yen SS; Pearson OH; Rankin JS
    Obstet Gynecol; 1968 Jul; 32(1):86-93. PubMed ID: 4316070
    [No Abstract]   [Full Text] [Related]  

  • 16. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gestational trophoblastic neoplasia].
    Langmár Z; Németh M
    Orv Hetil; 2011 Dec; 152(49):1971-3. PubMed ID: 22106165
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese trial for classification of gestational trophoblastic disease.
    Sasaki S; Sasaki Y
    J Reprod Med; 2008 Aug; 53(8):583-8. PubMed ID: 18773622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Human Chorionic Gonadotropin Normogram for the Detection of Gestational Trophoblastic Neoplasia.
    Eysbouts Y; Brouwer R; Ottevanger P; Massuger L; Sweep F; Thomas C; van Herwaarden A
    Int J Gynecol Cancer; 2017 Jun; 27(5):1035-1041. PubMed ID: 28498241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline No. 408: Management of Gestational Trophoblastic Diseases.
    Eiriksson L; Dean E; Sebastianelli A; Salvador S; Comeau R; Jang JH; Bouchard-Fortier G; Osborne R; Sauthier P
    J Obstet Gynaecol Can; 2021 Jan; 43(1):91-105.e1. PubMed ID: 33384141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.